Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 ...

Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Cronos Group plummeted more than 15% on November 9, 2021, after the company announced in an SEC filing that it should have taken an impairment charge of at ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

This was the stock's seventh consecutive day of losses.

This cheap stock is a favorite with Robinhood investors, but it's facing serious headwinds to future growth. It's been an up-and-down year for companies across all sectors of the stock market. The ...

Cannabinoid products producer Cronus Group (NASDAQ: CRON) stock has fallen over (-30%) from its $15.83 year-to-date (YTD) highs reached on Feb. 10, 2021 with the Nasdaq sell-off. To be fair, the whole ...

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Cronos Group Inc. dropped 15% on November 9, 2021, after the company announced in an SEC filing that it would be required to restate its financial ...

This cannabis company might have an obvious incentive for investors, but is that enough to earn it a place in your portfolio? Cronos is a global cannabis company that manufactures and sells medical ...